WEKO3
アイテム
Human T-cell leukemia virus type 1(HTLV1) infection in malignant lymphomas in a HTLV1-endemic area, Kagoshima, Japan : HTLV-1 in-situ-hybridization (ISH) analysis employing a highly biotinylated concatamer probe synthesized by polymerase chain reaction (PCR) for HTLV-1 proviral DNA pX Tax region
http://hdl.handle.net/10232/3738
http://hdl.handle.net/10232/37382b010c0a-ebbe-47ff-8ab1-6b03465b4743
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2010-04-13 | |||||||||
タイトル | ||||||||||
タイトル言語 | en | |||||||||
タイトル | Human T-cell leukemia virus type 1(HTLV1) infection in malignant lymphomas in a HTLV1-endemic area, Kagoshima, Japan : HTLV-1 in-situ-hybridization (ISH) analysis employing a highly biotinylated concatamer probe synthesized by polymerase chain reaction (PCR) for HTLV-1 proviral DNA pX Tax region | |||||||||
著者 |
Hasui, Kazuhisa
× Hasui, Kazuhisa
× Sato, Eiichi
|
|||||||||
言語 | ||||||||||
言語 | eng | |||||||||
キーワード | ||||||||||
主題言語 | en | |||||||||
主題Scheme | Other | |||||||||
主題 | Human T-cell leukemia virus type 1(HTLV-1) | |||||||||
キーワード | ||||||||||
主題言語 | en | |||||||||
主題Scheme | Other | |||||||||
主題 | Malignant lymphomas | |||||||||
キーワード | ||||||||||
主題言語 | en | |||||||||
主題Scheme | Other | |||||||||
主題 | HTLV-1 endemic area | |||||||||
キーワード | ||||||||||
主題言語 | en | |||||||||
主題Scheme | Other | |||||||||
主題 | In-situ-hybridization | |||||||||
キーワード | ||||||||||
主題言語 | en | |||||||||
主題Scheme | Other | |||||||||
主題 | HTLV-l pX Tax | |||||||||
資源タイプ | ||||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
資源タイプ | journal article | |||||||||
要約(Abstract) | ||||||||||
内容記述タイプ | Other | |||||||||
内容記述 | This study aimed to see HTLV-1 infection in 277 cases of malignant lymphoma (ML) in a HTLV-1indemic area by means of ISH employing a highly biotinylated concatamer probe synthesized by a couple of primers SK43 and 44 PCR for HTLV-1 provial DNA pX Tax region. The MLs comprised 115 T-cell MLs, 73 B-cell MLs, 14 Hodgkin's disease (HD) and MLs from the age group less than 20 years old (y.o.). The non-Hodgkin's MLs were categorized according to updated Kiel classification. ISH detected a signal of HTLV-1 proviral DNA including pX Tax region, showing positive stain dominantly in cytoplasm of lymphoma cells and non-neoplastic cells including intermingling small 1ymphocytes, histiocytes and epithelioid cells. ML in which lymphoma cells showed the signal was defined as ""HTLV-1-related ML"". And ML in which any cells revealed the signal was defined as ""HTLV-1-carrier ML"". HTLV-1-related MLs were found in all the subtypes of T-cell MLs (69/115, 60%), indicating its high rate (44/45, 97.8%) in T-cell pleomorphic lymphoma with histological features of adult T-cell leukemia/ lymphoma (ATLL). Even in MLs other than the T-cell MLs, HTLV-1ielated MLs were noted in 21 (29%) of B-cell MLs, 8 (57%) of HD and 4 (16%) of MLs from the age group less than 20 y.o.. HTLV-1-carrier MLs were found in 93 (81%) of T-cell MLs, 35 (49%) of B-cell MLs, 8 (57%) of HD, 13 (52%) of MLs from the age group less than 20 y.o.. HTLV-1-related T-cell MLs in which many lymphoma cells showed the signal may be ATLL, but it was unknown whether there were ATLLs in the ISH-negative cases and in HTLV-1-carrier MLs other than HTLV-1ielated MLs. Considering several technical problems in this ISH, the followings were suggested in this study. HTLV-1 may have oncogenetic effect(s) specific for ATLL and non-specific for MLs other than ATLL but ATLL development would need factor(s) other than HTLV-1 infection. There may be HTLV-1-related B-cell MLs and HD. Some of patients with B-cell MLs and in the under 20-year-old ML patients would fail to produce antibodies against HTLV-1, because higher HTLV-1 carrier rates in these patients were recognized in this study than in the serovirological studies. |
|||||||||
内容記述言語 | en | |||||||||
収録雑誌名 |
en : Dendritic cells 巻 4, p. 125-137, 発行日 1994-01-01 |
|||||||||
作成日 | ||||||||||
日付 | 1994-01-01 | |||||||||
日付タイプ | Issued | |||||||||
NII書誌ID(雑誌) | ||||||||||
収録物識別子タイプ | NCID | |||||||||
NC ID | AA11039557 | |||||||||
出版タイプ | ||||||||||
出版タイプ | VoR | |||||||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||
NDC | ||||||||||
主題Scheme | NDC | |||||||||
主題 | 490 | |||||||||
NIIsubject | ||||||||||
主題言語 | ja | |||||||||
主題Scheme | Other | |||||||||
主題 | 医学 | |||||||||
公開者・出版者 | ||||||||||
出版者言語 | ja | |||||||||
出版者 | 日本樹状細胞研究会 | |||||||||
公開者・出版者 | ||||||||||
出版者言語 | en | |||||||||
出版者 | Japanese Dendritic Cells Society |